SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
46 hedge funds and large institutions have $38.6M invested in Sorrento Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
+9
Holders Change %
+24.32%
% of All Funds
1.04%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
17
Increased
14
Reduced
9
Closed
8
Calls
$103K
Puts
$25K
Net Calls
+$78K
Net Calls Change
+$69K
Top Buyers
| 1 |
Millennium Management
New York
|
+$2.67M |
| 2 |
BlackRock
New York
|
+$1.14M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$845K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$834K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$427K |
Top Sellers
| 1 |
WCM
Wildcat Capital Management
New York
|
-$4.03M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$977K |
| 3 |
Renaissance Technologies
New York
|
-$397K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$209K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$150K |